As of May, 10 Analysts See $-0.12 EPS for Alphatec Holdings, Inc. (ATEC)

April 17, 2018 - By Joseph Norton

Alphatec Holdings, Inc. (NASDAQ:ATEC) Corporate Logo

Alphatec Holdings, Inc. (NASDAQ:ATEC)’s quarterly earnings will be reported On May, 10., according to Zacks. Analysts expect change of 80.00 % or $0.48 from previous year’s $-0.6 EPS compared to current’s $-0.12 EPS. Last quarter $0.39 EPS was reported. Analysts forecasts -130.77 % negative EPS growth this quarter. Its shares touched $3.58 on during the last trading session after 0.85% change.Alphatec Holdings, Inc. has 88,815 shares volume, 19.57% up from normal. ATEC is uptrending and has moved 52.40% since April 17, 2017. ATEC outperformed by 40.85% the S&P500.

Alphatec Holdings, Inc., a medical technology company, focuses on the design, development, manufacture, and marketing of products for the surgical treatment of spine disorders.The firm is valued at $91.47 million. The Company’s product and procedural portfolio, as well as pipeline address the cervical, thoracolumbar, and intervertebral regions of the spine; and cover various spinal disorders and surgical procedures.Currently it has negative earnings. The firm offers MIS products consisting of Battalion Lateral Spacer System and Squadron Lateral Retractor, XYcor Expandable Spinal Spacer System, Illico Minimally Invasive Surgery System, and BridgePoint Spinous Process Fixation System; and thoracolumbar fixation products, such as Arsenal Degenerative, Arsenal Deformity, Arsenal CBx Cortical Bone Fixation, and Zodiac Degenerative Spinal Fixation systems.

Alphatec Holdings, Inc. (NASDAQ:ATEC) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.